Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, highlights the importance of a call for evidence on AI regulation in MedTech. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a pivotal “Call
As the NHS 10 Year Health Plan moves from ambition to implementation, 2026 is shaping up to be a pivotal year for MedTech and digital health. Med-Tech Insights reached out to leaders from across the industry to ask them to share their expectations for the year ahead. From value-based procurement to
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers reports on a new collaboration to use nuclear waste in cancer-fighting MedTech. In a landmark move set to redefine cancer treatment, Bicycle
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers highlights a new UK/Singapore joint venture to encourage innovation in MedTech. The UK and Singapore have launched a groundbreaking “regulato
Flow Neuroscience has announced FDA approval of its breakthrough Flow at-home brain-stimulation device for the treatment of major depressive disorder (MDD). The company says the FDA approval marks the first time in history American clinicians are able to prescribe a novel at-home non-drug therapy as
Boston Scientific has announced that Health Care Service Corporation (HCSC), one of the largest commercial health insurers in the U.S., now covers the Intracept Procedure for eligible patients with chronic vertebrogenic low back pain. The policy went into effect December 1, 2025 and covers more than
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers assesses the positive implications for MedTech of a controversial decision to allow government to dictate the level of value thresholds adopt
Bethan Halliwell, Partner, and Lucy Tedstone, Associate, of European IP firm Withers & Rogers highlight the challenges of sustainable innovation, and explain how building an IP strategy with sustainability at its core can turn environmental responsibility into competitive advantage. Sustainability i
Bendit Technologies is proud to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Bendit17 Microcatheter, the smallest steerable microcatheter on the market. This milestone marks a significant step forward in advancing precision and accessibility in neuro
The landmark European clinical study EASEE4YOU, evaluating a pioneering neurostimulation therapy for adolescents with drug-resistant focal epilepsy, is set to launch in the UK, with Great Ormond Street Hospital (GOSH) joining the research programme. The study evaluates the EASEE System, a minimally
Median Technologies, manufacturer of eyonis, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, announced the signing of
Inspira Technologies has announced that the Japan Patent Office has granted Patent No. 7777598, covering the Company’s novel Convertible Dual Lumen Cannula device and method of use, securing exclusive rights in one of the world’s most advanced medical device markets. The patent grants Inspira exclus
